MetLife Inc 5.625% Series E Preferred Stock
MET.PRE
2 hedge funds and large institutions have $7.87M invested in MetLife Inc 5.625% Series E Preferred Stock in 2022 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
0.01% more ownership
Funds ownership: 0.94% → 0.95% (+0.01%)
0% more funds holding
Funds holding: 2 → 2 (0)
1% less capital invested
Capital invested by funds: $7.95M → $7.87M (-$86K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CGH
Crossmark Global Holdings
Houston,
Texas
|
+$117K |
Top Sellers
MET.PRE Hedge Fund Activity: Q1 2022 in Review
2 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in MetLife Inc 5.625% Series E Preferred Stock (MET.PRE) for Q1 2022, worth a combined $7.87M — down 1.1% from $7.95M a quarter earlier.
Fund positioning in MET.PRE was balanced in Q1 2022: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Crossmark Global Holdings, adding an estimated $117K.
- 2 institutional investors held MetLife Inc 5.625% Series E Preferred Stock (MET.PRE) as of Q1 2022, unchanged from Q4 2021.
- Funds reported $7.87M of MetLife Inc 5.625% Series E Preferred Stock stock for Q1 2022, down 1.1% quarter-over-quarter.
- 0 funds opened new MetLife Inc 5.625% Series E Preferred Stock positions in Q1 2022 and 0 closed out.
- The largest MetLife Inc 5.625% Series E Preferred Stock buyer in Q1 2022 was Crossmark Global Holdings, an estimated $117K added.
Based on aggregated 13F filings for Q1 2022.